UK Bowel Cancer screening Dr Voi Shim Wong BsC MD FRCP. Consultant Gastroenterologist Accredited BCSP colonoscopist Whittington + UCL Hospitals
|
|
- Mervin Heath
- 5 years ago
- Views:
Transcription
1 UK Bowel Cancer screening 2017 Dr Voi Shim Wong BsC MD FRCP Consultant Gastroenterologist Accredited BCSP colonoscopist Whittington + UCL Hospitals
2 Bowel Cancer Contents UK Bowel Cancer Screening Programme Bowel cancer screening in private practise
3 Normal Colon Anatomy
4 57F presented with acute large bowel obstruction
5 Prevalance of GI Cancers Liver/biliary 8% Pancreas 16% Oesophagus 16% Bowel/rectum 41% Stomach 19%
6 Distribution of CRC
7 CRC- some facts 2 nd commonest cause of cancer related death in western world 3 rd commonest cancer in UK (35,000 new cases / year, 16,000 deaths/ year) Differing overall survival rates in Europe * UK < France < Germany * ( 45 < 50 < 60 ) % Average 5 yr survival = 55 % 80 % cases are diagnosed at Dukes stages > B
8 N => adenoma => large adenoma => pre-malignant => cancer Normal => LGD => MGD => HGD => cancer
9 EMR of flat colonic polyps
10 Cancer risk in colorectal polyps
11 CRC - No. of New Cases Per Yr & Age-Specific Incidence Rates, UK,
12 Bowel Cancer : Five-Year Net Survival, E & W 5-yr net survival for CRC in men has increased from 25% ( ) to 59% (2011)
13 Colon Cancer : Year Relative Survival, Adults (Aged 15+), European Countries
14 Net Survival up to Ten Years after Diagnosis, (15-99), E & W
15 Bowel Cancer: Five-Year Net Survival by Age, England
16 What screening is testing people for early stages of an illness before they have any symptoms For screening to be useful the tests: must be reliable at picking up the illness must be simple and quick overall must do more good than harm to people taking part
17 CRC Screening Tests Non Invasive FOB x3 CEA Invasive CT Colography Flexible Sigmoidoscopy Colonoscopy Gold standard Colonoscopy
18 Gold standard 90% of adenomas can be seen and removed during colonoscopy
19 NHS Bowel Cancer Screening Current FOB testing Flexible sigmoidoscopy (Bowel Scope) Future? Virtual colonoscopy? Genetic markers in blood / stool / urine (Detection of CRC DNA quantification of exfoliated colonocytes)
20 FOB kit every 2 years FOBT You need to be registered with a GP to receive your screening invitations. In England, men and women years People >74, can request a screening kit by contacting the BCSP
21
22 UK Bowel Cancer Screening Programme 2 in 100 will receive an abnormal result colonoscopy. 4 in 100 people may receive an unclear result there was a slight suggestion of blood in the test sample. causes such as hemorrhoids FOB test will need to be repeated. Most people who repeat the test normal For those undergoing colonoscopy 5 in 10 people normal 4 in 10 polyp (s) 1 in 10 ==> cancer
23 Patient Pathway Positive FOBt Seen by Screening Practitioner (SSP) in outpatients Implications of + FOBt explained Colonoscopy offered within next 14 days Declines FOBt kit sent in 2 years Accepts Colonoscopy Biopsy/polypectomy Histology in 3-7 days Normal FOBt kit sent in 2 years Cancer detected Seen by Screening Practitioner For result Non-cancerous For treatment at UCLH SSP gives cancer diagnosis Introduces Colorectal CNS Refers to UCLH MDT For treatment at other hospitals SSP gives cancer diagnosis Refers to relevant MDT Surveillance as per BSCP protocol
24 STAGE UCLH PILOT Data Polyp Cancer (41) 16% 15% Dukes A (64) 25% 25% Dukes B (61) 24% 26% Dukes C (59) 23% 25% Dukes D (30) 12% 9%
25 So far..at UCH Polyp detection rate 33-45% (40%) Cancer detection rate % (10%)
26 NHS Bowel Scope Screening (BSS) Primarily a nurse led programme Running concurrently with FOBT Flexible sigmoidoscopy -55yrs only however, can opt in if under 60 years * Commenced 2013 Complete National roll-out by April 2018
27 NHS Bowel Scope Screening (BSS)
28
29 NHS Flexible Sigmoidoscopy Screening trial (UK FSST) Once only (55-64yrs) 190,000 (55%) responded 170,000 randomised (2 : 1) -> 57,000 assigned screening 40,000 (FS) Results 11.3yrs FU * 33% (50) reduction incidence * 43% decrease mortality
30 BOWEL SCOPE AT WHITTINGTON, APRIL 2015 TO APRIL 2017 Total number of Bowel Scopes 789 Colonoscopy 20 (or 2.5% total scopes) Occasions where patient attended but did not complete: 11
31 Result Count Abn - NND only 259 Abn- Polyps & NND Abn- Polyps found Cancer suspected Normal 321 Total 789 1
32 Polyp Class Count Polyp type Count Flat 34 Pedunculated 20 Sessile 226 Grand Total 280 Adenoma 76 Blank 8 Inflammatory polyp 5 Not polyp 32 Other polyp 5 Serrated lesion 83 Grand Total 209
33 Pathology Result Cancer + Polyps 1 High Risk 2 Intermediate Risk 11 Low Risk 5 Polyps to be categorised 1 Grand Total 20
34 Polyp by location and size Polyp location Count Polyp size Count Decending 40 Rectum 151 Sigmoid 84 Transverse 5 Grand Total mm mm mm mm mm 8 >10mm 10 Grand Total 280
35 Poylp Detection rate (PDR) & Adenoma Detection rate (ADR) BSS BoSS with polyp/s PDR % BoSS with adenoma/s ADR % A % % VSW % % Total % %
36 Patient comfort Clinician None Minimal Mild Moderate Severe Total A VSW Total
37 BCS in Private Practice Mirror current NHS programmes: FOBT BSS Those aged 55 missed out on current BSS Those with risk factors FH CRC IBD Genetic factors: e.g Lynch syndrome or FAP, acromegaly
38 Younger people <50 reviewed data on >1 million CRC in National Cancer Database USA No of CRC is rising ~ 1 % a year in < 50 the majority of cases still occur > 50 1: 7 CRC < 50 more likely to have advanced stage cancer but they live slightly longer without a cancer recurrence because they are treated aggressively DDW 2016: Sutton et al + J Cancer 2016
39 Conclusion 70% of CRC detected within the NHS screening programme is early stage disease = potentially curable endoscopically or by surgery NHS bowel cancer screening programme (FOBT & BSS) improved overall survival The challenges will be to increase participation /uptake through improved public awareness and to address socio-economic inequalities
40 Final Word CRC screening should be team work Treat individuals and Not numbers Options for screening be offered and risks explained Consider screening relatives
41
42
Bowel Cancer Screening
Bowel Cancer Screening Dr John Hancock FRCP Consultant Gastroenterologist University Hospital of North Tees Outline Background Current bowel cancer screening programme Tees Screening Centre Future Flexi
More informationNorthern Ireland Bowel Cancer Screening Programme. Pathways. Version 4 1 st October 2013
Northern Ireland Bowel Cancer Screening Programme Pathways These changes will be version controlled, led by the Quality Assurance Director for the Programme. Any updated versions will be circulated and
More informationColorectal cancer screening
26 Colorectal cancer screening BETHAN GRAF AND JOHN MARTIN Colorectal cancer is theoretically a preventable disease and is ideally suited to a population screening programme, as there is a long premalignant
More informationADENOMA SURVEILLANCE BCSP Guidance Note No 1 Version 1 September 2009
ADENOMA SURVEILLANCE BCSP Guidance Note No 1 Version 1 September 2009 Published by: NHS Cancer Screening Programmes Fulwood House Old Fulwood Road Sheffield S10 3TH Tel: 0114 271 1060 Fax: 0114 271 1089
More informationSCREENING FOR BOWEL CANCER USING FLEXIBLE SIGMOIDOSCOPY REVIEW APPRAISAL CRITERIA FOR THE UK NATIONAL SCREENING COMMITTEE
SCREENING FOR BOWEL CANCER USING FLEXIBLE SIGMOIDOSCOPY REVIEW APPRAISAL CRITERIA FOR THE UK NATIONAL SCREENING COMMITTEE The Condition 1. The condition should be an important health problem Colorectal
More informationNHS KINGSTON. Contents
NHS KINGSTON Contents 1. Background... 2 2. Targets and quality standards... 2 3. Service provision and performance... 3 Uptake... 3 Investigations... 6 Cancer detection... 7 Age extension... 7 4. Quality
More informationColorectal Cancer. Mark Chapman. MA MS FRCS EBSQ(coloproct) 21 st March 2018 Consultant Coloproctologist
Colorectal Cancer Mark Chapman MA MS FRCS EBSQ(coloproct) 21 st March 2018 Consultant Coloproctologist Overview Epidemiology of colorectal cancer Adenoma carcinoma sequence Tumour diagnosis & staging Treatment
More informationScreening for GI Cancer Past Present and Future. Prof. Bob Steele University of Dundee
Screening for GI Cancer Past Present and Future Prof. Bob Steele University of Dundee Worldwide Cancer Incidence Rates UK Cancer Incidence Rates Screening The detection of disease in asymptomatic subjects
More informationColon Cancer Screening. Layth Al-Jashaami, MD GI Fellow, PGY 4
Colon Cancer Screening Layth Al-Jashaami, MD GI Fellow, PGY 4 -Colorectal cancer (CRC) is a common and lethal cancer. -It has the highest incidence among GI cancers in the US, estimated to be newly diagnosed
More informationAlberta Colorectal Cancer Screening Program (ACRCSP) Post Polypectomy Surveillance Guidelines
Alberta Colorectal Cancer Screening Program (ACRCSP) Post Polypectomy Surveillance Guidelines June 2013 ACRCSP Post Polypectomy Surveillance Guidelines - 2 TABLE OF CONTENTS Background... 3 Terms, Definitions
More information2. Describe pros/cons of screening interventions (including colonoscopy, CT colography, fecal tests)
Learning Objectives 1. Review principles of colon adenoma/cancer biology that permit successful prevention regimes 2. Describe pros/cons of screening interventions (including colonoscopy, CT colography,
More informationScreening & Surveillance Guidelines
Chapter 2 Screening & Surveillance Guidelines I. Eligibility Coloradans ages 50 and older (average risk) or under 50 at elevated risk for colon cancer (personal or family history) that meet the following
More informationMissed Lesions at Endoscopy. Dr Russell Walmsley, MD, FRCP, FRACP Gastroenterologist WDHB Chair Endoscopy Guidance Group for New Zealand
Missed Lesions at Endoscopy Dr Russell Walmsley, MD, FRCP, FRACP Gastroenterologist WDHB Chair Endoscopy Guidance Group for New Zealand Missed Lesions at Endoscopy Is there a problem? With Gastroscopy
More informationPathology in Slovenian CRC screening programme:
Pathology in Slovenian CRC screening programme: Findings, organisation and quality assurance Snježana Frković Grazio University Medical Center Ljubljana, Slovenia Slovenia s population: 2 million Incidence
More informationBe it Resolved that FIT is the Best Way to Screen for Colorectal Cancer DEBATE
Be it Resolved that FIT is the Best Way to Screen for Colorectal Cancer DEBATE DEBATE Presenters PRESENTATION MODERATOR Dr. Praveen Bansal -MD, CCFP FCFP Regional Primary Care Lead, Integrated Cancer Screening,
More informationProf Stephen P. Halloran. Update on the NHS Bowel Cancer Screening Programme Focus on BS & FIT
Prof Stephen P. Halloran Update on the NHS Bowel Cancer Screening Programme Focus on BS & FIT World Top 20 Cancers Men Incidence & Mortality (2012) Women World Colorectal Cancer 3 rd commonest cancer 4
More informationWhen is a programmed follow-up meaningful and how should it be done? Professor Alastair Watson University of Liverpool
When is a programmed follow-up meaningful and how should it be done? Professor Alastair Watson University of Liverpool Adenomas/Carcinoma Sequence Providing Time for Screening Normal 5-20 yrs 5-15 yrs
More informationBowel Cancer Screening Exploiting science brings better medicine
Camberley & District Bowel Cancer Screening Exploiting science brings better medicine Prof Stephen P. Halloran World - All Cancers Men Incidence & Mortality (2012) Women Incidence Mortality GLOBOCAN 2012
More informationObjectives. Definitions. Colorectal Cancer Screening 5/8/2018. Payam Afshar, MS, MD Kaiser Permanente, San Diego. Colorectal cancer background
Colorectal Cancer Screening Payam Afshar, MS, MD Kaiser Permanente, San Diego Objectives Colorectal cancer background Colorectal cancer screening populations Colorectal cancer screening modalities Colonoscopy
More informationColon Screening in 2014 Offering Patients a Choice. Clark A Harrison MD The Nevada Colon Cancer Partnership
Colon Screening in 2014 Offering Patients a Choice Clark A Harrison MD The Nevada Colon Cancer Partnership Objectives 1. Understand the incidence and mortality rates for CRC in the US. 2. Understand risk
More informationNHS Bowel Cancer Screening Programme
NHS Bowel Cancer Screening Programme Wolverhampton Bowel Cancer Screening Centre Annual Report April 2016 to March 2017 @RWT_NHS Introduction Bowel cancer is the fourth most common cancer in the UK after
More informationNHS Bowel Cancer Screening Programme
NHS Bowel Cancer Screening Programme Wolverhampton Bowel Cancer Screening Centre Annual Report April 2015 to March 2016 Introduction Bowel cancer is the fourth most common cancer in the UK (2012) accounting
More informationExperience and challenges of implementing optical diagnosis into clinical practice UK and European Perspective
Experience and challenges of implementing optical diagnosis into clinical practice UK and European Perspective WEO Image Enhanced Endoscopy San Diego, USA Dr James East Consultant Gastroenterologist Honorary
More informationFaecal Immunochemical Testing (FIT) for Screening and Symptomatic Patients
Faecal Immunochemical Testing (FIT) for Screening and Symptomatic Patients Caroline Addison NE BCSP Hub Director and Consultant Clinical Scientist What is FIT Type of Faecal Occult Blood test Designed
More informationTo: all bowel screening centre directors and programme managers. Dear colleague
Professor Julietta Patnick CBE Director JP/LC 11 January 2013 To: all bowel screening centre directors and programme managers Fulwood House Old Fulwood Road Sheffield S10 3TH Tel: 0114 271 1060 Fax: 0114
More informationColorectal cancer screening in England
Colorectal cancer screening in England critical analysis Prof Stephen P. Halloran Participation Rate 57% All Screens (1.9% +ve) 52% Prevalent 1 st Screen (age 60 years) 36% Prevalent Screen (2.2% +ve)
More informationColorectal Cancer Screening. Daniel C. Chung, MD GI Unit and GI Cancer Genetics Service Massachusetts General Hospital
Colorectal Cancer Screening Daniel C. Chung, MD GI Unit and GI Cancer Genetics Service Massachusetts General Hospital March, 2018 CRC Epidemiology 4th most common malignancy in US (136,000 cases/yr) 2nd
More informationEmerging Interventions in Endoscopy. Margaret Vance Nurse Consultant in Gastroenterology St Mark s Hospital
Emerging Interventions in Endoscopy Margaret Vance Nurse Consultant in Gastroenterology St Mark s Hospital Colon Cancer Colon cancer is common. 1 in 20 people in the UK will develop the disease 19 000
More informationColon Cancer Screening. A Provider Opinion Survey
Colon Cancer Screening A Provider Opinion Survey 1. Background Information What is colon cancer? Who needs to be screened? Colorectal Cancer» Presence of abnormal cells in the colon or rectum that divide
More informationBowel Cancer Prevention and Screening. Harriet Wynne, Cancer Council Victoria
Bowel Cancer Prevention and Screening Harriet Wynne, Cancer Council Victoria New cases and deaths for the Victoria population in 2013 Thursfield V, et al. Cancer in Victoria: Statistics & trends 2013.
More informationNICaN workshop: Colorectal Cancer Follow-up
NICaN workshop: Colorectal Cancer Follow-up The Changing Picture of Colorectal Cancer in Northern Ireland Dr Helen Coleman Lecturer in Cancer Epidemiology & CRUK Population Research Postdoctoral Fellow
More informationColon Cancer Screening Past, Present & Future
Colon Cancer Screening Past, Present & Future Steve Lanspa, MD August 25, 2018 Dr. Lanspa has listed no financial interest/arrangement that would be considered a conflict of interest. Learning Objectives
More informationColorectal Cancer Screening
Colorectal Cancer Screening December 5, 2017 Connecticut Cancer Partnership 14th Annual Meeting Xavier Llor, M.D., PhD. Associate Professor of Medicine Co-Director, Cancer Genetics and Prevention Program
More informationBowel Screening Colonoscopy in Glasgow How well are we doing? How well should we be doing? How can we evidence and improve performance?
Bowel Screening Colonoscopy in Glasgow 2017 How well are we doing? How well should we be doing? How can we evidence and improve performance? Bowel Screening Standards - Scotland Definitions Completion
More informationTransforming Cancer Services for London
Programme Director Paul Roche Status Draft Owner Laura Boyd Version 0.4 Author Jennifer Layburn Date 15/05/13 Transforming Cancer Services for London Best Practice Commissioning Pathway for the early detection
More informationImproving Outcomes in Colorectal Cancer: The Science of Screening. Colorectal Cancer (CRC)
Improving Outcomes in Colorectal Cancer: The Science of Screening Tennessee Primary Care Association October 23, 2014 Durado Brooks, MD, MPH Director, Prostate and Colorectal Cancers Colorectal Cancer
More information11/9/2015 OUTLINE. Quality Indicators for the Doctor Performing Screening Colonoscopy: What you should expect from your Endoscopist
Quality Indicators for the Doctor Performing Screening Colonoscopy: What you should expect from your Endoscopist Anil K Sharma MD FACP Professor of Clinical Medicine, University of Rochester Chief of Gastroenterology,
More informationGI Screening/Surveillance in Lynch Syndrome
GI Screening/Surveillance in Lynch Syndrome M Appleyard Royal Brisbane and Women s Hospital Brisbane, Australia GI Disease and Lynch Syndrome What are risks of GI disease in Lynch? Who do we screen for
More informationColonCancerCheck & Regional Updates. Cheryl Shoemaker RN, BScN, CON(C) March 19, 2014
ColonCancerCheck & Regional Updates Cheryl Shoemaker RN, BScN, CON(C) March 19, 2014 Colorectal Cancer Facts 3 rd most commonly diagnosed cancer 2nd leading cause of cancer death in men & 3 rd cancer death
More informationService specification No. 26A NHS bowel scope screening programme
Service specification No. 26A NHS bowel scope screening programme NHS England INFORMATION READER BOX Directorate Medical Commissioning Operations Patients and Information Nursing Trans. & Corp. Ops. Commissioning
More informationColon Cancer Screening and Surveillance. Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011
Colon Cancer Screening and Surveillance Louis V. Antignano, M.D. Wilson Gastroenterology October 11, 2011 Colorectal Cancer Preventable cancer Number 2 cancer killer in the USA Often curable if detected
More informationPrevention of Bowel Cancer: which patients do I send for colonoscopy?
Prevention of Bowel Cancer: which patients do I send for colonoscopy? Dr Chris Groves Consultant Gastroenterologist and Honorary Senior Lecturer St George s Hospital and Medical School Director, SW London
More informationFREQUENTLY ASKED QUESTIONS
FREQUENTLY ASKED QUESTIONS What is CRC? CRC (CRC) is cancer of the large intestine (colon), the lower part of the digestive system. Rectal cancer is cancer of the last several inches of the colon. Together,
More informationSurveying the Colon; Polyps and Advances in Polypectomy
Surveying the Colon; Polyps and Advances in Polypectomy Educational Objectives Identify classifications of polyps Describe several types of polyps Verbalize rationale for polypectomy Identify risk factors
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Colorectal cancer: colonoscopic surveillance for prevention of colorectal cancer in patients with ulcerative colitis, Crohn
More information05/07/2018. Organisation. The English screening programme what is happening? Organisation. Bowel cancer screening in the UK is:
Organisation The English screening programme what is happening? Phil Quirke Lead Pathologist Bowel Cancer Screening PHE England Bowel Cancer Screening Pathology Committee Started 2006 with roll out 4 devolved
More informationCost-effectiveness of an early awareness campaign for colorectal cancer
Cost-effectiveness of an early awareness for colorectal cancer Sophie Whyte 1, Sue Harnan 1, Paul Tappenden 1, Mark Sculpher 2, Seb Hinde 2, Claire Mckenna 2 Policy Research Unit in Economic Evaluation
More informationNorthern Ireland Bowel Cancer Screening Programme
Northern Ireland Bowel Cancer Screening Programme Inaugural Report April 2010 March 2013 Published: 30 October 2014 (amended: 3 December 2014) 2 P a g e Contents Contents... 3 Foreword... 7 1 Introduction...
More informationremoval of adenomatous polyps detects important effectively as follow-up colonoscopy after both constitute a low-risk Patients with 1 or 2
Supplementary Table 1. Study Characteristics Author, yr Design Winawer et al., 6 1993 National Polyp Study Jorgensen et al., 9 1995 Funen Adenoma Follow-up Study USA Multi-center, RCT for timing of surveillance
More informationColorectal Cancer Screening: Cost-Effectiveness and Adverse events October, 2005
Colorectal Cancer Screening: Cost-Effectiveness and Adverse events October, 2005 David Lieberman MD Chief, Division of Gastroenterology Oregon Health and Science University Portland VAMC Portland, Oregon
More informationDouglas K. Rex, MD Indiana University Hospital Indianapolis, IN
Serrated Adenomas: What do they mean and what to do about them? Douglas K. Rex, MD Indiana University Hospital Indianapolis, IN Colorectal Cancer Molecular Basis Pathway Frequency Genes MSI Precursor Speed
More informationColorectal Cancer Screening in Ohio CHCs. Ohio Association of Community Health Centers
Colorectal Cancer Screening in Ohio CHCs Ohio Association of Community Health Centers 2 1/29/2015 Your Speakers Dr. Ted Wymyslo Ashley Ballard Randy Runyon 3 1/29/2015 Facts 3 rd most common cancer in
More informationCarol A. Burke, MD, FACG
Updated Guidelines for CRC C Screening and Surveillance Carol A. Burke MD, FACG, FASGE, FACP Cleveland Clinic, Cleveland, OH Gastroenterology t 2012;143:844 143 Gut 2010;59:666 1 Caveat for all Recommendations
More informationDebate: General surveillance/screening for colon cancer in a resource constrained environment is imperative
Debate: General surveillance/screening for colon cancer in a resource constrained environment is imperative Dr. Meryl Oyomno Department of surgery, University of Pretoria INTRODUCTION Screening is the
More informationMinimising the consequences of colorectal cancer treatment
Minimising the consequences of colorectal cancer treatment Muti Abulafi Consultant Colorectal Surgeon Croydon University Hospital Chair, Colorectal Pathway Group London Cancer Alliance In two words Early
More informationAn Update on the Bowel Cancer Screening Programme. Natasha Djedovic, London Hub Director 17 th September 2018
An Update on the Bowel Cancer Screening Programme Natasha Djedovic, London Hub Director 17 th September 2018 NHS Bowel Cancer Screening Programme 2006: 60-69 yr old men & women offered guaiac Faecal Occult
More informationA TEST FOR COLORECTAL CANCER THAT IS 92% SENSITIVE AND NON-INVASIVE. Stool DNA test
A TEST FOR COLORECTAL CANCER THAT IS 92% SENSITIVE AND NON-INVASIVE Stool DNA test THE NEW NON-INVASIVE SCREENING TEST FOR COLORECTAL CANCER Sensitive Clinically proven 1 Easy to use FDA approved COLOGUARD
More informationCaring for a Patient with Colorectal Cancer. Objectives. Poll question. UNC Cancer Network Presented on 10/15/18. For Educational Use Only 1
Caring for a Patient with Colorectal Cancer Tammy Triglianos RN, APRN-BC, AOCNP Nurse Practitioner, GI Oncology 10/15/2018 Objectives Describe common signs and symptoms of colorectal cancer Understand
More informationNHS Bowel Cancer Screening Programmes: Evaluation of pilot of Faecal Immunochemical Test : Final report.
NHS Bowel Cancer Screening Programmes: Evaluation of pilot of Faecal Immunochemical Test : Final report. Sue Moss, Christopher Mathews Centre for Cancer Prevention, Wolfson Institute, Queen Mary University
More informationCT Colonography. A Radiologist s View of the Colon from Outside-In. Donny Baek, MD
CT Colonography A Radiologist s View of the Colon from Outside-In Donny Baek, MD Computed Tomography (CT) CT Image Reconstruction CT Image Reconstruction CT Image Reconstruction Colorectal Cancer Annual
More informationColorectal Cancer Screening in Later Life: Blum Center Rounds
Colorectal Cancer Screening in Later Life: Blum Center Rounds OCTOBER 10, 2018 Agenda CRC Screening and Surveillance Recommendation Screening for Colon Cancer later in life Discussion and listening Families
More informationInformation for families with a slightly increased risk of bowel cancer. Family History of Bowel Cancer
Information for families with a slightly increased risk of bowel cancer Family History of Bowel Cancer How common is bowel cancer? Bowel cancer is the 3rd most common cancer in the UK. 1 in 20 people develop
More informationGrand Rounds. Des Moines University. May 5, Durado Brooks, MD, MPH Director, Cancer Control Intervention American Cancer Society
Grand Rounds Des Moines University May 5, 2016 Durado Brooks, MD, MPH Director, Cancer Control Intervention American Cancer Society Case Summary Mrs. J is a 56 y o w female complaining of always tired;
More informationCLINICAL PRACTICE GUIDELINE FOR COLORECTAL CANCER SCREENING
CLINICAL PRACTICE GUIDELINE FOR COLORECTAL CANCER SCREENING This guideline is designed to assist practitioners by providing the framework for colorectal cancer (CRC) screening, and is not intended to replace
More informationNational Screening Programmes (Adult Population) Annual Report
National Screening Programmes (Adult Population) Annual Report 2011-12 1 This report details the range of national screening programmes for the adult population offered by NHS Shetland and reports the
More informationNeoplastic Colon Polyps. Joyce Au SUNY Downstate Grand Rounds, October 18, 2012
Neoplastic Colon Polyps Joyce Au SUNY Downstate Grand Rounds, October 18, 2012 CASE 55M with Hepatitis C, COPD (FEV1=45%), s/p vasectomy, knee surgery Meds: albuterol, flunisolide, mometasone, tiotropium
More informationColorectal Cancer Screening
Recommendations from the U.S. Multi-Society Task Force on Colorectal Cancer Colorectal Cancer Screening Rex DK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Levin TR, Lieberman D, Robertson
More informationColorectal Cancer Screening and Surveillance
1 Colorectal Cancer Screening and Surveillance Jeffrey Lee MD, MAS Assistant Clinical Professor of Medicine University of California, San Francisco jeff.lee@ucsf.edu Objectives Review the various colorectal
More informationBowel screening cancer prevention
Bowel screening cancer prevention David S Morrison Consultant in Public Health Medicine 22 nd September 2016 Bowel cancer incidence since 1979 http://www.cancerresearchuk.org/healthprofessional/cancer-statistics/statistics-by-cancertype/bowel-cancer/incidence#heading-two
More informationChallenges for Colorectal Cancer Screening
Challenges for Colorectal Cancer Screening a Biomarker with No Standards! Prof. Emeritus Stephen P. Halloran University of Surrey W. Europe Top 20 Cancers Men Incidence & Mortality (2012) Women World -
More informationQuality of and compliance with colonoscopy in Lynch Syndrome surveillance: are we getting it right?
Quality of and compliance with colonoscopy in Lynch Syndrome surveillance: are we getting it right? Hartery K 1, Sukha A 1, Thomas-Gibson S 1, Thomas H 1,2, Latchford A 1,2. 1 Wolfson Endoscopy Unit, St.
More informationThe New Grade A: USPSTF Updated Colorectal Cancer Screening Guidelines, What does it all mean?
The New Grade A: USPSTF Updated Colorectal Cancer Screening Guidelines, What does it all mean? Robert A. Smith, PhD Cancer Control, Department of Prevention and Early Detection American Cancer Society
More informationGUIDANCE ON THE INDICATIONS FOR DIAGNOSTIC UPPER GI ENDOSCOPY, FLEXIBLE SIGMOIDOSCOPY AND COLONOSCOPY
Position Statement produced by BSG, AUGIS and ACPGBI GUIDANCE ON THE INDICATIONS FOR DIAGNOSTIC UPPER GI ENDOSCOPY, FLEXIBLE SIGMOIDOSCOPY AND COLONOSCOPY Introduction In 2011 the Independent Practice
More informationSetting The setting was primary and secondary care. The economic study was carried out in Taiwan.
Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries Wu G H, Wang Y W, Yen A M, Wong J M, Lai H C, Warwick J, Chen T H Record Status This
More informationEarly detection and screening for colorectal neoplasia
Early detection and screening for colorectal neoplasia Robert S. Bresalier Department of Gastroenterology, Hepatology and Nutrition. The University of Texas. MD Anderson Cancer Center. Houston, Texas U.S.A.
More informationWhy FIT (Faecal Immunochemical Test) is the best biomarker for CRC screening
Why FIT (Faecal Immunochemical Test) is the best biomarker for CRC screening Prof. Stephen Halloran Royal Surrey County Hospital NHS Cancer Screening Programme University of Surrey gfobt Guaiacum Officinale
More informationAnnual Report. Public Health Screening Programmes TO 31 MARCH Extract: Chapter 3 : Planning for Bowel Screening Programme
Public Health Screening Programmes Annual Report TO 31 MARCH 2007 Extract: Chapter 3 : Planning for Bowel Screening Programme Version 1.0 Published: 18 December 2007 1 Contents INTRODUCTION...3 SUMMARY...5
More informationColorectal Neoplasia. Dr. Smita Devani MBChB, MRCP. Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi
Colorectal Neoplasia Dr. Smita Devani MBChB, MRCP Consultant Physician and Gastroenterologist Aga Khan University Hospital, Nairobi Case History BT, 69yr male Caucasian History of rectal bleeding No change
More informationOutcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests
Gut Online First, published on December 7, 2011 as 10.1136/gutjnl-2011-300843 Colorectal cancer 1 Division of Epidemiology and Public Health, University of Nottingham, Nottingham, UK 2 NHS Cancer Screening
More informationColorectal Cancer: Preventable, Beatable, Treatable. American Cancer Society
Colorectal Cancer: Preventable, Beatable, Treatable American Cancer Society Reviewed/Revised May 2018 What we ll be talking about How common is colorectal cancer? What is colorectal cancer? What causes
More informationColon Cancer Screening & Surveillance. Amit Patel, MD PGY-4 GI Fellow
Colon Cancer Screening & Surveillance Amit Patel, MD PGY-4 GI Fellow Epidemiology CRC incidence and mortality rates vary markedly around the world. Globally, CRC is the third most commonly diagnosed cancer
More informationWEO CRC SC Meeting. Barcelona, Spain October 23, 2015
WEO CRC SC Meeting Barcelona, Spain October 23, 2015 Identification of serrated polyposis syndrome in the context of population-based CRC screening programs Evelien Dekker Academic Medical Center Amsterdam,
More informationIs there justification for levels of polyp competency? Dr Roland Valori Gloucestershire Hospitals United Kingdom
Is there justification for levels of polyp competency? Dr Roland Valori Gloucestershire Hospitals United Kingdom What exactly will be required? Defining levels of polypectomy competency in terms of complexity/time/risk
More informationLIST OF ABBREVIATIONS
Gastroenter oenterology 2005 Royal College of Physicians of Edinburgh Screening and surveillance for upper and lower gastrointestinal cancer JN Plevris Consultant Gastroenterologist and Honorary Senior
More informationColorectal Cancer Screening Guideline Issue Brief Updated May 30 th, 2018
Colorectal Cancer Screening Guideline Issue Brief Updated May 30 th, 2018 Issue Summary The American Cancer Society has updated its colorectal screening guideline, which have been published in CA: A Journal
More informationCOLORECTAL SCREENING PROGRAMME: IMPACT ON THE HOSPITAL S PATHOLOGY SERVICES SINCE ITS INTRODUCTION.
The West London Medical Journal 2009 Vol No 1 pp 23-31 COLORECTAL SCREENING PROGRAMME: IMPACT ON THE HOSPITAL S PATHOLOGY SERVICES SINCE ITS INTRODUCTION. Competing interests: None declared ABSTRACT Sarah
More informationJoint Session with ACOFP and Cancer Treatment Centers of America (CTCA): Cancer Screening: Consensus & Controversies. Ashish Sangal, M.D.
Joint Session with ACOFP and Cancer Treatment Centers of America (CTCA): Cancer Screening: Consensus & Controversies Ashish Sangal, M.D. Cancer Screening: Consensus & Controversies Ashish Sangal, MD Director,
More informationCancer Screening Programmes BOWEL CANCER SCREENING. The Facts
Cancer Screening Programmes BOWEL CANCER SCREENING The Facts What is the aim of this leaflet? This leaflet gives you information about bowel cancer, and the benefits and risks of bowel cancer screening.
More informationCommunity Bowel Screening Volunteers (CBSV) Project: Outcomes and Impact of the Pilot Phase
Jonny Hirst, Regional Manager (North West) October 2017 Community Bowel Screening Volunteers (CBSV) Project: Outcomes and Impact of the Pilot Phase Contents 1. Executive Summary... 2 2. Context: Bowel
More informationPolyps Adenomas Lipomas
30 Chapter 2 CT Colonography Chapter 2 Polyps Adenomas Lipomas Case 8 Case 9 Case 10 Case 11 Case 12 Case 13 Case 14 Case 15 Case 16 Case 17 Case 18 Pseudopolyp Polyp after intravenous administration of
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Kaminski MF, Regula J, Kraszewska E, et al. Quality indicators
More informationGENETIC MANAGEMENT OF A FAMILY HISTORY OF FAP or MUTYH ASSOCIATED POLYPOSIS. Family Health Clinical Genetics. Clinical Genetics department
GENETIC MANAGEMENT OF A FAMILY HISTORY OF FAP or MUTYH ASSOCIATED POLYPOSIS Full Title of Guideline: Author (include email and role): Division & Speciality: GUIDELINES FOR THE GENETIC MANAGEMENT OF A FAMILY
More information(Bowel) Cancer Screening an update. Mike Hulme-Moir Colorectal Surgeon CD NZ Bowel Screening Pilot
(Bowel) Cancer Screening an update Mike Hulme-Moir Colorectal Surgeon CD NZ Bowel Screening Pilot Screening The application of tests, examinations or other procedures. to sort out apparently well persons
More informationBowel scope screening
NHS Bowel Cancer Screening Programme Bowel scope screening I ve been invited for NHS bowel scope screening. This leaflet gives you information to help you choose whether to have screening. NHS bowel scope
More informationNATIONAL SCREENING COMMITTEE
Optimising Bowel Cancer Screening Phase 1: Optimising the cost effectiveness of repeated FIT screening and screening strategies combining bowel scope and FIT screening Sophie Whyte, Chloe Thomas, Ben Kearns,
More informationGuidelines for Colonoscopy Surveillance After Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer
Guidelines for Colonoscopy Surveillance After Screening and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer David A. Lieberman, 1 Douglas K. Rex, 2 Sidney J. Winawer,
More informationColorectal Cancer Screening: Colonoscopy, Potential and Pitfalls. Disclosures: None. CRC: still a major public health problem
Colorectal Cancer Screening: Colonoscopy, Potential and Pitfalls Disclosures: None Jonathan P. Terdiman, M.D. Professor of Clinical Medicine University of California, San Francisco CRC: still a major public
More informationPost-polypectomy follow-up after. removal of colorectal neoplasia
Post-polypectomy follow-up after removal of colorectal neoplasia Post-polypectomy endoscopic surveillance For each type of polyp BENEFIT 1. What is the risk of CRC/Adv. Neo. (AN) w/out surveillance?
More informationACG Clinical Guideline: Colorectal Cancer Screening
ACG Clinical Guideline: Colorectal Cancer Screening Douglas K. Rex, MD, FACG 1, David A. Johnson, MD, FACG 2, Joseph C. Anderson, MD 3, Phillip S. Schoenfeld, MD, MSEd, MSc (Epi), FACG 4, Carol A. Burke,
More information